Table 1.
Antigens | HPB-AML-I | UCBTERT-21 [15] | F6 [21] | ISCT criteria [2] | Wang et al. [18] | Lee et al. [22] | Majore et al. [23] |
---|---|---|---|---|---|---|---|
CD14 | - | - | - | - | - | - | ND |
CD19 | - | ND | ND | - | - | ND | ND |
CD29 | + | + | + | ND | + | ND | ND |
CD34 | - | - | - | - | - | ND | ND |
CD44 | + | + | + | ND | + | + | + |
CD45 | - | - | - | - | - | ND | ND |
CD55 | + | + | ND | ND | ND | ND | ND |
CD59 | + | + | ND | ND | ND | ND | ND |
CD73 | + | ND | ND | + | + | ND | + |
CD90 | - | - | ND | + | ND | + | + |
CD105 | - | ND | ND | + | + | + | + |
CD117 | - | - | ND | ND | ND | ND | ND |
HLA-DR | - | ND | - | - | - | ND | ND |
ND: not determined